A scientific abstract isn’t supposed to be as hard to interpret as modern art. Nikki Teran and Ray Futia, two Stanford Biosciences PhD students, give you an inside look into the research their peers are doing. Each episode they are joined by the author of a recent peer reviewed paper to discuss the paper's abstract in plain English and make it a little Less Abstract.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Laure Frésard, Nicole Ferraro, & Nikki Teran: IDing Rare Disease Genes
9:09
9:09
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
9:09
Nikki Teran, Laure Frésard, and Nicole Ferraro talk about their work diagnosing rare diseases. We pick apart their abstract to see how they, along with other clinicians and scientists, look at differences between the RNA from patient's and healthy people's blood in order to find out which genes are broken. See the full article at: https://www.natur…
…
continue reading
We talk with Dirk Spencer about his recent work at Simon Gilroy’s lab at UW Madison where he helped lead author, Masatusugu Toyota, observe plants reacting to being eaten by caterpillars. Join us as we pick apart their abstract to see how they used fluorescent markers to begin to dissect plant “intelligence”.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Tess Branon: Directing Evolution to Craft New Biotechnology
9:10
9:10
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
9:10
We talk with Tess Branon about TurboID, a new tool she developed in Alice Ting's lab at MIT and Stanford University. TurboID can be added to any protein to label what’s around it, letting scientists find out what a protein’s doing by who it’s interacting with — even in whole animals. We pick apart Tess's abstract to see how she used directed evolut…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Abhiram Rao: PCSK9 & Drug Safety Prediction
4:56
4:56
बाद में चलाएं
बाद में चलाएं
सूचियाँ
पसंद
पसंद
4:56
We look at Stanford grad student, Abhiram Rao's study on a gene named PCSK9, which makes a protein involved in cholesterol regulation. We pick apart his abstract to see how he used genomics to show that PCSK9 inhibitor drugs could protect against stroke. See the original article at: www.ahajournals.org/doi/10.1161/CIRCGEN.118.002162…
…
continue reading